Targeted colonic release formulations of mesalazine – A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis-Reference-Cited by-同舟云学术

Targeted colonic release formulations of mesalazine – A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis

Published:2022-09 Issue: Volume:625 Page:122055
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Varum F.,Thorne H.,Bravo R.,Gilgen D.,Hartig C.,Nicolas G.P.,Wild D.,Liakoni E.,Haschke M.

Funder

Tillotts Pharma

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference49 articles.

1. Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon;Abrahamsson;Int. J. Pharm.,1996

2. Effects of thermal neutron irradiation on some potential excipients for colonic delivery systems;Ahrabi;Drug Dev. Ind. Pharm.,1999

3. Influence of neutron activation factors on the physico-chemical properties of suppositories and their excipients;Ahrabi;Eur. J. Pharm. Sci.,1999

4. Influence of neutron activation factors on matrix tablets for site specific delivery to the colon;Ahrabi;Eur. J. Pharm. Sci.,2000

5. Fecal microbiota transplantation capsules with targeted colonic versus gastric delivery in recurrent Clostridium difficile infection: a comparative cohort analysis of high and low dose;Allegretti;Digest Dis. Sci.,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of proctitis in ulcerative colitis and the place of biological therapies;Expert Opinion on Biological Therapy;2024-06-02

2. Enteric-Coated Capsules Providing Reliable Site-Specific Drug Delivery to the Distal Ileum;Molecular Pharmaceutics;2024-05-09

3. The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome;Journal of Controlled Release;2024-05

4. Microbiota-sensitive drug delivery systems based on natural polysaccharides for colon targeting;Drug Discovery Today;2023-07

5. Dendrobium as a new natural source of bioactive for the prevention and treatment of digestive tract diseases: A comprehensive review with future perspectives;Phytomedicine;2023-06